CYTH - Cyclo Therapeutics EPS beats by $0.07 beats on revenue November, 15 2021 05:08 PM Cyclo Therapeutics Inc. Cyclo Therapeutics (NASDAQ:CYTH): Q3 GAAP EPS of -$0.60 beats by $0.07. Revenue of $0.4M (+81.8% Y/Y) beats by $0.02M. Press Release For further details see: Cyclo Therapeutics EPS beats by $0.07, beats on revenue